Disc Medicine, Inc. (IRON)Healthcare | Biotechnology | Watertown, United States | NasdaqGM
60.48 USD
|
Hot Take ↕ | Oct. 10, 2026, 1:35 a.m. EDT
The investment case for Disc Medicine is currently broken by a severe lack of profitability and a deteriorating price trend. Despite a recent year-over-year price rebound, the company has suffered four consecutive years of negative annual returns, indicating that the market views the business quality as fundamentally compromised. Financially, the picture is stark: the company is burning cash with negative free cash flow and negative operating cash flow, while returning equity to shareholders via insider sales rather than dividends. The balance sheet shows significant leverage relative to equity, and the negative earnings per share confirm that the core business is not yet generating sustainable profits. While analysts project significant upside potential, this appears to be a speculative bet on a clinical trial success rather than a value proposition supported by current fundamentals. The options market reflects this skepticism, with heavy put buying suggesting investors are hedging against further declines. Until the company demonstrates consistent revenue growth and positive cash flow, the risk profile remains extreme. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.069972 |
| MSTL | 0.070390 |
| AutoARIMA | 0.070406 |
| AutoTheta | 0.075489 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 35% |
| H-stat | 80.80 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.062 |
| Excess Kurtosis | -1.29 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 9.448 |
| Market Cap | 2,321,999,104 |
| Forward P/E | -8.54 |
| Beta | 2.11 |
| Website | https://www.discmedicine.com |
As of Oct. 10, 2026, 1:35 a.m. EDT: Speculators are aggressively positioning for downside protection, evidenced by massive put volume and open interest at strikes significantly below the current price (e.g., $45 and $55), while call activity remains thin and concentrated near the money. The implied volatility skew suggests fear of a sharp decline, with traders betting against the stock's immediate prospects despite some recent price recovery.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.17150682 |
| Address1 | 321 Arsenal Street |
| Address2 | Suite 101 |
| All Time High | 572.55 |
| All Time Low | 15.0 |
| Ask | 77.67 |
| Ask Size | 1 |
| Audit Risk | 9 |
| Average Analyst Rating | 1.1 - Strong Buy |
| Average Daily Volume10 Day | 754,870 |
| Average Daily Volume3 Month | 479,425 |
| Average Volume | 479,425 |
| Average Volume10Days | 754,870 |
| Beta | 2.11 |
| Bid | 56.05 |
| Bid Size | 2 |
| Board Risk | 7 |
| Book Value | 16.799 |
| City | Watertown |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 8 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 60.48 |
| Current Ratio | 24.136 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 60.48 |
| Day Low | 60.16 |
| Debt To Equity | 9.448 |
| Display Name | Disc Medicine |
| Dividend Yield | 0.0 |
| Earnings Timestamp | 1,785,414,600 |
| Earnings Timestamp End | 1,793,881,800 |
| Earnings Timestamp Start | 1,793,881,800 |
| Ebitda | -268,058,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -6.212 |
| Enterprise Value | 1,665,115,264 |
| Eps Current Year | -6.56 |
| Eps Forward | -7.08 |
| Eps Trailing Twelve Months | -6.58 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 73.205 |
| Fifty Day Average Change | -12.725002 |
| Fifty Day Average Change Percent | -0.17382695 |
| Fifty Two Week Change Percent | -17.150682 |
| Fifty Two Week High | 99.5 |
| Fifty Two Week High Change | -39.02 |
| Fifty Two Week High Change Percent | -0.3921608 |
| Fifty Two Week Low | 40.0 |
| Fifty Two Week Low Change | 20.48 |
| Fifty Two Week Low Change Percent | 0.51199996 |
| Fifty Two Week Range | 40.0 - 99.5 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,597,239,000,000 |
| Float Shares | 32,910,730 |
| Forward Eps | -7.08 |
| Forward P E | -8.542373 |
| Free Cashflow | -117,543,128 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 165 |
| Fullday Change | 0.0 |
| Fullday Change Percent | 0.0 |
| Fullday Price | 60.48 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.07837 |
| Held Percent Institutions | 1.14113 |
| Implied Shares Outstanding | 38,392,844 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,672,358,400 |
| Last Split Factor | 1:30 |
| Long Business Summary | Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and DISC-3405 for the treatment of polycythemia vera, and other hematologic disorders. It also develops preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. The company was founded in 2017 and is headquartered in Watertown, Massachusetts. |
| Long Name | Disc Medicine, Inc. |
| Market | us_market |
| Market Cap | 2,321,999,104 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_641326926 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -245,888,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 2,536,615,203 |
| Number Of Analyst Opinions | 12 |
| Open | 60.16 |
| Operating Cashflow | -197,536,000 |
| Operating Margins | 0.0 |
| Overall Risk | 7 |
| Phone | 617 674 9274 |
| Previous Close | 60.48 |
| Price Eps Current Year | -9.219512 |
| Price Hint | 2 |
| Price To Book | 3.6002142 |
| Profit Margins | 0.0 |
| Quick Ratio | 23.641 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.07692 |
| Region | US |
| Regular Market Change | 0.0 |
| Regular Market Change Percent | 0.0 |
| Regular Market Day High | 60.48 |
| Regular Market Day Low | 60.16 |
| Regular Market Day Range | 60.16 - 60.48 |
| Regular Market Open | 60.16 |
| Regular Market Previous Close | 60.48 |
| Regular Market Price | 60.48 |
| Regular Market Time | 1,791,898,210 |
| Regular Market Volume | 5,409 |
| Return On Assets | -0.23963 |
| Return On Equity | -0.39082 |
| Sand P52 Week Change | 0.17502642 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 4 |
| Shares Outstanding | 38,392,844 |
| Shares Percent Shares Out | 0.1894 |
| Shares Short | 7,270,420 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 7,365,002 |
| Short Name | Disc Medicine, Inc. |
| Short Percent Of Float | 0.2208 |
| Short Ratio | 12.69 |
| Source Interval | 15 |
| State | MA |
| Symbol | IRON |
| Target High Price | 128.0 |
| Target Low Price | 83.0 |
| Target Mean Price | 103.16667 |
| Target Median Price | 100.0 |
| Total Cash | 717,745,984 |
| Total Cash Per Share | 18.695 |
| Total Debt | 60,862,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -6.58 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 71.11413 |
| Two Hundred Day Average Change | -10.634129 |
| Two Hundred Day Average Change Percent | -0.14953609 |
| Type Disp | Equity |
| Volume | 5,409 |
| Website | https://www.discmedicine.com |
| Zip | 2,472 |